Measuring longitudinal cognition: Individual tests versus composites

by Erin M. Jonaitis, Rebecca L. Koscik, Lindsay R. Clark, Yue Ma, Tobey J. Betthauser, Sara E. Berman, Samantha L. Allison, Kimberly D. Mueller, Bruce P. Hermann, Carol A. Van Hulle, Bradley T. Christian, Barbara B. Bendlin, Kaj Blennow, Henrik Zetterberg, Cynthia M. Carlsson, Sanjay Asthana, Sterling C. Johnson
Published 2019-12-01

APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease

by Elles Konijnenberg, Betty M. Tijms, Johan Gobom, Valerija Dobricic, Isabelle Bos, Stephanie Vos, Magda Tsolaki, Frans Verhey, Julius Popp, Pablo Martinez-Lage, Rik Vandenberghe, Alberto Lleó, Lutz Frölich, Simon Lovestone, Johannes Streffer, Lars Bertram, Kaj Blennow, Charlotte E. Teunissen, Robert Veerhuis, August B. Smit, Philip Scheltens, Henrik Zetterberg, Pieter Jelle Visser
Published 2020-05-01

Research diagnostic criteria for Alzheimer’s disease: findings from the LipiDiDiet randomized controlled trial

by Anna Rosenberg, Alina Solomon, Hilkka Soininen, Pieter Jelle Visser, Kaj Blennow, Tobias Hartmann, Miia Kivipelto, on behalf of the LipiDiDiet clinical study group
Published 2021-03-01

Mild Cognitive Impairment Staging Yields Genetic Susceptibility, Biomarker, and Neuroimaging Differences

by Elizabeth E. Moore, Dandan Liu, Kimberly R. Pechman, Lealani Mae Y. Acosta, Susan P. Bell, Susan P. Bell, L. Taylor Davis, L. Taylor Davis, Kaj Blennow, Kaj Blennow, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Bennett A. Landman, Bennett A. Landman, Bennett A. Landman, Matthew S. Schrag, Timothy J. Hohman, Timothy J. Hohman, Katherine A. Gifford, Angela L. Jefferson, Angela L. Jefferson
Published 2020-06-01

Neurological assessment and its relationship to CSF biomarkers in amateur boxers.

by Sanna Neselius, Helena Brisby, Jan Marcusson, Henrik Zetterberg, Kaj Blennow, Thomas Karlsson
Published 2014-01-01

Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study

by Steinunn Thordardottir, Elena Rodriguez-Vieitez, Ove Almkvist, Daniel Ferreira, Laure Saint-Aubert, Anne Kinhult-Ståhlbom, Håkan Thonberg, Michael Schöll, Eric Westman, Anders Wall, Maria Eriksdotter, Henrik Zetterberg, Kaj Blennow, Agneta Nordberg, Caroline Graff
Published 2018-05-01

Cerebrovascular Biomarker Profile Is Related to White Matter Disease and Ventricular Dilation in a LADIS Substudy

by Maria Bjerke, Michael Jonsson, Arto Nordlund, Carl Eckerström, Kaj Blennow, Henrik Zetterberg, Leonardo Pantoni, Domenico Inzitari, Reinhold Schmidt, Anders Wallin
Published 2014-10-01

Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study

by Marie Eckerström, Staffan Nilsson, Henrik Zetterberg, Kaj Blennow, Anna Grahn
Published 2020-12-01

Cerebrospinal fluid and plasma neurofilament light relate to abnormal cognition

by Katie E. Osborn, Omair A. Khan, Hailey A. Kresge, Corey W. Bown, Dandan Liu, Elizabeth E. Moore, Katherine A. Gifford, Lealani Mae Y. Acosta, Susan P. Bell, Timothy J. Hohman, Kaj Blennow, Henrik Zetterberg, Angela L. Jefferson
Published 2019-12-01

Plasma tau complements CSF tau and P‐tau in the diagnosis of Alzheimer's disease

by Silvia Fossati, Jaime Ramos Cejudo, Ludovic Debure, Elizabeth Pirraglia, Je Yeong Sone, Yi Li, Jingyun Chen, Tracy Butler, Henrik Zetterberg, Kaj Blennow, Mony J. deLeon
Published 2019-12-01

Cognitive performance and cerebrospinal fluid biomarkers of neurodegeneration: a study of patients with bipolar disorder and healthy controls.

by Sindre Rolstad, Joel Jakobsson, Carl Sellgren, Carl-Johan Ekman, Kaj Blennow, Henrik Zetterberg, Erik Pålsson, Mikael Landén
Published 2015-01-01

The 12-Word Philadelphia Verbal Learning Test Performances in Older Adults: Brain MRI and Cerebrospinal Fluid Correlates and Regression-Based Normative Data

by Katherine A. Gifford, Dandan Liu, Jacquelyn E. Neal, Michelle A. Babicz, Jennifer L. Thompson, Lily E. Walljasper, Margaret E. Wiggins, Maxim Turchan, Kimberly R. Pechman, Katie E. Osborn, Lealani Mae Y. Acosta, Susan P. Bell, Timothy J. Hohman, David J. Libon, Kaj Blennow, Henrik Zetterberg, Angela L. Jefferson
Published 2018-12-01

Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression

by Christopher Clark, Piotr Lewczuk, Johannes Kornhuber, Jonas Richiardi, Bénédicte Maréchal, Thomas K. Karikari, Kaj Blennow, Henrik Zetterberg, Julius Popp
Published 2021-03-01

The circadian rest-activity pattern predicts cognitive decline among mild-moderate Alzheimer’s disease patients

by Adriano D. S. Targa, Iván D. Benítez, Faridé Dakterzada, John Fontenele-Araujo, Olga Minguez, Henrik Zetterberg, Kaj Blennow, Ferran Barbé, Gerard Piñol-Ripoll
Published 2021-09-01

Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease

by Hákon Valur Dansson, Lena Stempfle, Hildur Egilsdóttir, Alexander Schliep, Erik Portelius, Kaj Blennow, Henrik Zetterberg, Fredrik D. Johansson, for the Alzheimer’s Disease Neuroimaging Initiative (ADNI)
Published 2021-09-01

CSF levels of the BACE1 substrate NRG1 correlate with cognition in Alzheimer’s disease

by François Mouton-Liger, Julien Dumurgier, Emmanuel Cognat, Claire Hourregue, Henrik Zetterberg, Hugo Vanderstichele, Eugeen Vanmechelen, Elodie Bouaziz-Amar, Kaj Blennow, Jacques Hugon, Claire Paquet
Published 2020-07-01